alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EX-10.1



 Exhibit 10.1 

2017 EQUITY INCENTIVE PLAN OF 

FUSE MEDICAL, INC. 

AMENDMENT NO. 4 

June 28, 2018 

Section 4.1. Section 4.1 of the 2017 Equity Incentive Plan of Fuse Medical, Inc., dated April 5, 2017, is removed in its
entirety and replaced by the following: 
 4.1    Subject to adjustment in accordance with Section 11, a total of
8,000,000 shares of Common Stock shall be available for the grant of Awards under the Plan; provided, however, that Incentive Stock Options granted to any single individual in a calendar year may not exceed $100,000 in Fair Market Value. Any
shares of Common Stock granted in connection with Options and Stock Appreciation Rights shall be counted against this limit as one (1) share for every one (I) Option or Stock Appreciation Right awarded. Any shares of Common Stock granted
in connection with Awards other than Options and Stock Appreciation Rights shall be counted against this limit as two (2) shares of Common Stock for every one (1) share of Common Stock granted in connection with such Award. During the
terms of the Awards, the Company shall keep available at all times the number of shares of Common Stock required to satisfy such Awards. 
  

			
	Fuse Medical, Inc.
		
	By:	 	/s/ William E. McLaughlin, III
		 	William E. McLaughlin, III
		 	Chief Financial Officer
<PAGE>

                                  EXHIBIT 8.1

                        SUBSIDIARIES OF MFC BANCORP LTD.

<Table>
<Caption>
NAME                                                 JURISDICTION OF INCORPORATION   SHAREHOLDERS YEAR END
----                                                 -----------------------------   ---------------------
<S>                                                  <C>                             <C>
MFC Merchant Bank S.A.                                        Switzerland                     100%
Constitution Insurance Company of Canada                        Canada                        100%
Hovis GmbH                                                      Austria                      95.5%
TriMaine Holdings, Inc.                                   State of Washington                  81%
Trimble Resources Corporation                                   Canada                       53.3%
Drummond Financial Corporation                            State of Washington                50.1%(1)
</Table>

---------------

(1) MFC owns 3.0 million preferred shares of Drummond Financial Corporation
    ("Drummond"), which gives MFC, in the aggregate, control of 76% of the
    voting power in Drummond.

                                        65
<TABLE> <S> <C>


<ARTICLE> 5
<MULTIPLIER> 1000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               SEP-30-1996
<CASH>                                           5,218
<SECURITIES>                                     1,581
<RECEIVABLES>                                   18,723
<ALLOWANCES>                                     2,137
<INVENTORY>                                      1,608
<CURRENT-ASSETS>                                30,734
<PP&E>                                          32,905
<DEPRECIATION>                                  19,741
<TOTAL-ASSETS>                                  80,621
<CURRENT-LIABILITIES>                           25,052
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           168
<OTHER-SE>                                      45,061
<TOTAL-LIABILITY-AND-EQUITY>                    80,621
<SALES>                                              0
<TOTAL-REVENUES>                                83,427
<CGS>                                                0
<TOTAL-COSTS>                                   64,044
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 826
<INCOME-PRETAX>                                 18,832
<INCOME-TAX>                                     6,636
<INCOME-CONTINUING>                             12,196
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    12,196
<EPS-PRIMARY>                                      .83
<EPS-DILUTED>                                      .83
        


</TABLE>
# L_2005102EN.01001901.xml

| 21.4.2005 | EN | Official Journal of the European Union | L 102/19 |
| --- | --- | --- | --- |

21.4.2005

EN

Official Journal of the European Union

L 102/19

---

DECISION OF THE EEA JOINT COMMITTEE

No 147/2004

of 29 October 2004

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area, as amended by the Protocol adjusting the Agreement on the European Economic Area, hereinafter referred to as ‘the Agreement’, and in particular Article 98 thereof,

Whereas:

| (1) | Annex II to the Agreement was amended by Decision of the EEA Joint Committee No 126/2004 of 24 September 2004 (1). |
| --- | --- |

(1)

Annex II to the Agreement was amended by Decision of the EEA Joint Committee No 126/2004 of 24 September 2004 (1).

| (2) | Commission Regulation (EC) No 1101/2004 of 10 June 2004 amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (2) is to be incorporated into the Agreement, |
| --- | --- |

(2)

Commission Regulation (EC) No 1101/2004 of 10 June 2004 amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (2) is to be incorporated into the Agreement,

HAS DECIDED AS FOLLOWS:

Article 1

The following indent shall be added in point 14 (Council Regulation (EEC) No 2377/90) in Chapter XIII of Annex II to the Agreement:

| ‘— | 32004 R 1101: Commission Regulation (EC) No 1101/2004 of 10 June 2004 (OJ L 211, 12.6.2004, p. 3).’ |
| --- | --- |

‘—

32004 R 1101: Commission Regulation (EC) No 1101/2004 of 10 June 2004 (OJ L 211, 12.6.2004, p. 3).’

Article 2

The texts of Regulation (EC) No 1101/2004 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.

Article 3

This Decision shall enter into force on 30 October 2004, provided that all the notifications under Article 103(1) of the Agreement have been made to the EEA Joint Committee (*1).

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.

Done at Brussels, 29 October 2004.

For the EEA Joint Committee

The President

Kjartan JÓHANNSSON

---

(1)  
  OJ L 64, 10.3.2005, p. 49.

1

(2)  
  OJ L 211, 12.6.2004, p. 3.

2

(*1)  No constitutional requirements indicated.

*1

---
Navigate to Homepage
Search
Main navigation
  

        
              Explore the Capitol Campus
                          Art
                            Buildings & Grounds
                            Capitol Hill Facts
                            Visitor Resources
                            Our Blog
                            What We Do
                          Areas of Expertise
                            Programs & Ceremonies
                            Projects
                            Publications
                            Strategic Objectives
                            About Us
                          Who We Are
                            History of the AOC
                            News & Notices
                            Organizational Structure
                            Partnerships & Recognition
                            Work With UsSearch Breadcrumb
    HomeExplore the Capitol CampusThe Art Collection
James Zachariah George Statue
        
                  The Basics
      
Artist
      
Augustus Lukeman

Materials
    Bronze

Year
    1931

Location
      
U.S. Capitol Visitor Center

This statue of James Zachariah George was given to the National Statuary Hall Collection by Mississippi in 1931.

James Zachariah George, Mississippi's "Great Commoner," was born on October 20, 1826, in Monroe County, Georgia, but moved to Mississippi when his widowed mother remarried. He served as a private in the Mexican War under Jefferson Davis. On his return, George studied law and was admitted to the bar. In 1854 he became a reporter of the Supreme Court of Mississippi, and over the next 20 years he prepared a 10-volume digest of its cases. As a member of the Mississippi Secession Convention, he signed the Ordinance of Secession.

A Confederate colonel during the Civil War, he was captured twice and spent two years in prison, where he conducted a law course for his fellow prisoners. After the war, he returned to the practice of law. In 1879 he was appointed to the Mississippi Supreme Court and immediately was chosen chief justice by his colleagues.

From 1881 until his death he represented Mississippi in the United States Senate, where he was recognized for his skills in debate, helped frame the future Sherman Anti-Trust Act, introduced the bill for agricultural college experiment stations, and encouraged the establishment of the Department of Agriculture. He also served as a member of the Mississippi Constitutional Convention of 1890 and successfully defended the constitution before the Senate and the Supreme Court. George died on August 14, 1897, in Mississippi City, Mississippi, where he had gone for health treatment. Serve. Preserve. Inspire.

              Contact Us
                            Accountability
                            Hill Staff Resources
                            AOC Staff Resources
Utility
  

        
              Privacy Policy
                            Image Terms of Use
                            Inspector General
                            U.S. Botanic Garden
                            U.S. Capitol Visitor CenterFacebook
	Twitter
	Flickr
	YouTube
	Instagram
	Subscribe
# C o u rt o f

A p p ea ls

o f t h e S t a te o f

G eo rg ia

ATLANTA,_

_ _ __ _ _ __ _ __ _ _ _ _ _ __ _ Th e Co u rt

o f Ap p ea l s h er eb y p a s s es t h e f

o ll owi n g o r der :

A1 6 A0 12 9 . DEI VI POLANO v . PATRI C I A RODRI GUEZ

.
Dei v i Po l an o fi l ed t h i s ap p eal fro m t he s u peri o r co urt ’ s fi n al d ecree o f d i v o rce. T h e Su p rem e Co u rt , h o wev er, h as g en eral ap pel l at e j u ri s d i ct i o n o v er d i v orce a n d al i m o n y cas es

. See Ga. Co n st . o f 1 9 8 3 , Art . VI, Sec. VI, Par. III (6 ). Acco rd i n g l y , t h i s ap p l i cat i o n i s h ereb y TRANSFERRED t o t h e Su p rem e Co urt fo r d i s po s i t i o n

.

C o u r t o f A p p e a l s o f t h e S t a t e o

f G e o r g ia C le r k ’ s O f f i c e , A t la n t a ,

_

_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ I c e r t i f y th a t t h e a b o v e i s a t r u e e x t r a c t f r o m
t h e m i n u t e s o

f t h e C o u r t o

f A p p e a l s o f G e o r g i a

. W i tn e s s m y s i g n a t u r e a n d t h e s e a l o

f s a i d c o u r t h e r e t o a f f i x e d t h e d a y a n d y e a r l a s t a b o v e w r i t t e n

.

, C l e r k

. 

## 09/22/2015 September 22, 2015
# EUR-Lex - 21999A1204(01) - EN

Avis juridique important

*|*

# 21999A1204(01)

**Agreement in the form of an Exchange of Letters concerning the provisional application of the Agreement on Trade, Development and Cooperation between the European Community and its Member States, of the one part, and the Republic of South Africa, of the other part **

*
Official Journal L 311 , 04/12/1999 P. 0002 - 0002 *

AGREEMENT IN THE FORM OF AN EXCHANGE OF LETTERS

concerning the provisional application of the Agreement on Trade, Development and Cooperation between the European Community and its Member States, of the one part, and the Republic of South Africa, of the other part

A. Letter from the Community

Pretoria, 11 October 1999

Sir,

I have the honour to refer to the Agreement on Trade, Development and Cooperation between the European Community and its Member States, of the one part, and the Republic of South Africa, of the other part, signed today.

Pending the entry into force of the said Agreement, I have the Honour to propose to you that the European Community and South Africa apply provisionally as from 1 January 2000, Articles 1 to 3, 5 to 28, 65 to 82, 93 to 97 and 99 to 109, Annexes I to VII and X and Protocols I and II of the Agreement.

If the above is acceptable to South Africa, this letter and your confirmation shall together constitute an agreement between the European Community and the Republic of South Africa.

Please accept, Sir, the assurance of our highest appreciation,

On behalf of the European Community

>PIC FILE= "L_1999311EN.000202.TIF">

>PIC FILE= "L_1999311EN.000203.TIF">

B. Letter from South Africa

Pretoria, 11 October 1999

Sir,

I have the honour to acknowledge receipt of your letter of today's date which, reads as follows: "I have the honour to refer to the Agreement on Trade, Development and Cooperation between the European Community and its Member States, of the one part, and the Republic of South Africa, of the other part, signed today.

Pending the entry into force of the said Agreement, I have the honour to propose to you that the European Community and South Africa apply provisionally as from 1 January 2000, Articles 1 to 3, 5 to 28, 65 to 82, 93 to 97 and 99 to 109, Annexes I to VII and X and Protocols I and II of the Agreement.

If the above is acceptable to South Africa, this letter and your confirmation shall together constitute an agreement between the European Community and the Republic of South Africa."

I am able to confirm that South Africa is in agreement with the contents of your letter.

Please accept, Sir, the assurance of my highest appreciation,

On behalf of the Government of the Republic of South Africa

>PIC FILE= "L_1999311EN.000204.TIF">
FORMAL RECOMMENDATION BY THE

NATIONAL ORGANIC STANDARDS BOARD (NOSB) 

TO THE NATIONAL ORGANIC PROGRAM (NOP) 

Date: ____11-11-06____________________

Subject: Sunset Renewal Vote for Colors, Non-synthetic under 205.605a, Nonsynthetics 

allowed. 

Chair: Kevin O’Rell 

 

Recommendation

The NOSB hereby recommends to the NOP the following: 

Rulemaking Action: _XXX___ 

Guidance Statement: ________ 

Other: ________ 

Statement of the Recommendation (including Recount of Vote):

The Board recommends NOT renewing Colors, nonsynthetic sources only, under 205.605a 

nonsynthetics allowed. 

NOSB Vote: Motion: Julie Weisman Second: Nancy Ostiguy 

Board vote: Yes - 12 No- 2 Abstain- 0 Absent - 0 

Rationale Supporting Recommendation (including consistency with OFPA and NOP):

Sunset Material Vote 

Response by the NOP:
National Organic Standards Board 

Final Sunset Recommendation for Colors, Non-synthetic 

October 19, 2006 

I. List: 205.605 Nonagricultural (nonorganic) substances allowed as ingredients in or on 

processed products labeled as “organic” or “made with organic (specified ingredients or 

food groups.” 

(a) Nonsynthetics allowed 

II. Committee Summary: 

There were many comments recommending the continued allowance of non-synthetic colors in 

organic handling. The federal register notice regarding Sunset Review asked the public to provide 

evidence and address concerns for any substance they believed should be discontinued. There 

was a comment addressing the concern that colors and flavors were added to the National List 

without a technical review by the NOSB. The Handling Committee requested and received a 

technical overview of food color additives on October 14, 2005. This technical review offered no 

information that would suggest that non-synthetic colors are inconsistent with organic practices. 

There were numerous comments opposing renewing the listing of non-synthetic colors. A few 

commenters requested that they be moved to 205.606, an action which cannot be taken as part 

of Sunset. Several commenters cited that non-synthetic colors had been placed on the National 

List without being petitioned and without the recommendation of the NOSB. The Board finds merit 

in this observation. Colors, non-synthetic cannot be renewed through the Sunset process 

because there was never an NOSB recommendation for its placement on the National List. 

III. Board Recommendation 

The handling committee recommends not renewing the following substances in this use category, 

effective the Sunset date of October 22, 2007: 

Colors, nonsynthetic sources only 

Board vote: 

Moved: Julie Weisman Second: Nancy Ostiguy

Board vote: Yes- 12 No-2 Absent-0
#### Schonleber v. A Reef Adventure, Inc.

23631

07/18/2001

Vacated and Remanded
An equal opportunity employer Thomas M. Gray 211(b) Technical Manager

1220 L Street, Northwest Washington, DC 20005-4070

Tel 202-682-8480

Fax 202-682-8270 E-mail grayt@api.org

June 9, 2010

Karl Simon

Division Director Compliance and Innovative Strategies Division Office of Transportation and Air Quality 1200 Pennsylvania Avenue, N. W.

Mail Code: 6406J Washington, DC 20460

RE: CAA Section 211(b) Fuels and Fuel Additives Hea lth Effects Testing Regulation: Final Submission for 211(b) (Docket No. A-90-07) 211(b) Chronic Carcinogenicity Study Baseline G asoline Vapor Condensate (BGVC) (LRRI Study No. FY01-027)

Dear Mr. Karl Simon:

The American Petroleum Institute (API), on behalf of the Section 211(b) Research Group (RG), is submitting the following information to EPA as partial fulfillment of the CAA Section 211(b) Alternative Tier 2 requirements of the testing regulation:

• 211(b) Chronic Carcinogenicity Study Baselin e Gasoline Vapor Condensate (BGVC) (LRRI Study No. FY01-027)

The Final Report has undergone review by two independent peer-reviewers, outside QA/QC, EPA and the 211(b) Technical Workgroup. Therefore the report is being submitted to you at the EPA Office of Transportation and Air Quality, Transportation and Regional Programs Division, as part of the requirements of Clean Air Act Section 211(b)(2) and 211(e) (Docket No. A-90-07). If you require further information or have any questions regarding this submission, please contact me.

Regards,

Thomas M. Gray, M.S., DABT

Encl (1): 211(b) Chronic Carcinogenicity Study Base line Gasoline Vapor Condensate (BGVC) (LRRI Study No. FY01-027)

Cc: Joe Sopata, EPA
LASERSIGHT INCORPORATED

                                                                    Exhibit 32.2


                    Certifications of Chief Financial Officer
  Pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code

      Pursuant  to 18 U.S.C.  Section  1350,  as created  by Section  906 of the
Sarbanes-Oxley  Act of 2002,  each of the  undersigned  officers  of  LaserSight
Incorporated (the "Company") does hereby certify that:

      1. The  Quarterly  Report on Form 10-QSB of the Company for the  quarterly
      period ended  September 30, 2005 (the  "Report")  fully  complies with the
      requirements  of Section 13(a) or Section  15(d),  as  applicable,  of the
      Securities Exchange Act of 1934, as amended; and

      2.  The  information  contained  in the  Report  fairly  presents,  in all
      material  respects,  the financial  condition and results of operations of
      the Company.



                                                  / S Dorothy M. Cipolla
Dated: November 8, 2005
                                   ---------------------------------------------
                                                        Dorothy M. Cipolla,
                                                      Chief Financial Officer

      The  certifications  set forth  above are being  furnished  as an  exhibit
solely  pursuant to Section 1350 of Chapter 63 of Title 18 of the United  States
Code,  and shall not be deemed to be "filed"  for  purposes of Section 18 of the
Securities  Exchange  Act  of  1934,  as  amended,  nor  shall  they  be  deemed
incorporated  by reference in any filing under the  Securities  Act of 1934,  as
amended.

      A signed original of this written  statement  required by Section 1350, or
other document authenticating, acknowledging or otherwise adopting the signature
that  appears  in typed  form  within the  electronic  version  of this  written
statement required by Section 1350, has been provided to LaserSight Incorporated
and will be retained by LaserSight  Incorporated and furnished to the Securities
and Exchange Commission or its staff upon request.
<TABLE> <S> <C>


<ARTICLE>                     5
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                            DEC-31-1997
<PERIOD-START>                               JAN-01-1997
<PERIOD-END>                                 JUN-30-1997
<CASH>                                        17,675,211
<SECURITIES>                                           0
<RECEIVABLES>                                  3,410,293
<ALLOWANCES>                                           0
<INVENTORY>                                            0
<CURRENT-ASSETS>                              21,085,504
<PP&E>                                        78,075,105
<DEPRECIATION>                                47,978,830
<TOTAL-ASSETS>                                30,096,275
<CURRENT-LIABILITIES>                          1,027,423
<BONDS>                                       15,840,764
<PREFERRED-MANDATORY>                                  0
<PREFERRED>                                            0
<COMMON>                                               0
<OTHER-SE>                                    34,314,009
<TOTAL-LIABILITY-AND-EQUITY>                  51,182,196
<SALES>                                                0
<TOTAL-REVENUES>                               8,677,144
<CGS>                                                  0
<TOTAL-COSTS>                                          0
<OTHER-EXPENSES>                               7,000,050
<LOSS-PROVISION>                                       0
<INTEREST-EXPENSE>                               601,672
<INCOME-PRETAX>                                1,075,422
<INCOME-TAX>                                           0
<INCOME-CONTINUING>                            1,075,422
<DISCONTINUED>                                         0
<EXTRAORDINARY>                                        0
<CHANGES>                                              0
<NET-INCOME>                                   1,075,422
<EPS-PRIMARY>                                          0
<EPS-DILUTED>                                          0
        


</TABLE>